Skip to content

TAG Reacts to J&J Commitment to Not Enforce Patents on Bedaquiline

  • Dorrit Walsh
TAG is thrilled by this weekend’s announcement that following years of activist pressure, Johnson & Johnson (J&J) has finally publicly committed to not enforcing its spurious secondary patents on bedaquiline in the treatment of drug-resistant tuberculosis (DR-TB) in 134 low- and middle-income countries.
Read more
Back To Top